Universal Fe/Mn Nanoadjuvant with T1/T2 MRI Self-Navigation and Gas Generation for Ideal Vaccines with Precise Tracking

ACS Nano. 2023 Aug 22;17(16):15590-15604. doi: 10.1021/acsnano.3c02309. Epub 2023 Aug 2.

Abstract

Because of the distinguished properties between nanovaccine and traditional vaccine, the precise guidelines for nanovaccines with an optimal vaccination strategy to induce ideal immunities are greatly desired for combating major diseases, including cancer and infections. Herein, we designed and synthesized a self-navigating nanoadjuvant composed of Fe-doped manganese carbonate and its nanovaccine via a facile method. First, the degradation of the nanoadjuvant under acidic milieu of immune cells in lymph nodes would generate T1 and T2 MR imaging (MRI) signals to reflect the transformation dynamics of the nanovaccine and inform us when the next vaccination needed. Under this guideline, nanovaccines with a precise vaccination strategy triggered robust antigen-specific immune responses and immunological memory to effectively prevent ovalbumin (OVA)-expressing melanoma relapse by activating dendritic cells via a stimulator of interferon genes (STING) signaling pathway and inducing antigen cross-presentation by shaping lysosome integrity with CO2 generation and upregulating transporter associated antigen processing 1 (TAP-1) transporter. This study provides a universal nanoadjuvant with imaging self-guidance, immunopotentiating, and cross-priming activities for developing precise vaccines with an optimal immunization strategy to combat major diseases.

Keywords: MR imaging; antigen cross-presentation; nanoadjuvant; precise vaccination; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigen Presentation
  • Cancer Vaccines*
  • Dendritic Cells
  • Humans
  • Immunotherapy / methods
  • Magnetic Resonance Imaging
  • Melanoma* / pathology
  • Mice
  • Mice, Inbred C57BL
  • Nanoparticles* / chemistry
  • Neoplasms* / metabolism
  • Vaccination
  • Vaccines*

Substances

  • Vaccines
  • Cancer Vaccines